What does MacroGenics, Inc. do?

Jun 22 2025 06:27 PM IST
share
Share Via
MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on developing monoclonal antibody-based therapies for cancer, autoimmune disorders, and infectious diseases. As of March 2025, it has a market capitalization of $86.43 million, with net sales of $13 million and a net loss of $41 million.
Overview:
MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases, operating in the Pharmaceuticals & Biotechnology industry with a micro-cap market capitalization.

Financial Snapshot:
Most recent Net Sales: 13 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -41 Million (Quarterly Results - Mar 2025)
Market-cap: USD 86.43 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.88
Return on Equity: -70.54%
Price to Book: 1.09

Contact Details:
Address: 9704 Medical Center Dr, ROCKVILLE MD: 20850-3343
Tel: 1 301 2515172
Website: https://www.macrogenics.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is MacroGenics, Inc. technically bullish or bearish?
Sep 20 2025 07:30 PM IST
share
Share Via
Is MacroGenics, Inc. overvalued or undervalued?
Sep 20 2025 06:06 PM IST
share
Share Via
Is MacroGenics, Inc. technically bullish or bearish?
Jun 25 2025 08:36 AM IST
share
Share Via
Who are in the management team of MacroGenics, Inc.?
Jun 22 2025 10:21 PM IST
share
Share Via
How big is MacroGenics, Inc.?
Jun 22 2025 05:50 PM IST
share
Share Via